Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study
Even after PS weighting analysis, some residual confounders may remain; however, sarcopenia was independently associated with adverse clinical outcomes, particularly mortality and bleeding risk. Screening for sarcopenia may enhance risk stratification and management, particularly in patients receiving anticoagulation.
Authors
- Hanjin Park (ORCID: https://orcid.org/0000-0002-7965-532X)
- Ung Kim (ORCID: https://orcid.org/0000-0002-6009-1843)
- Boyoung Joung (ORCID: https://orcid.org/0000-0001-9036-7225)
- Han‐Joon Bae (ORCID: https://orcid.org/0000-0001-7212-9979)
- Daehoon Kim (ORCID: https://orcid.org/0000-0002-9736-450X)
- Jang‐Won Son (ORCID: https://orcid.org/0000-0002-8109-5018)
- Pil‐Sung Yang (ORCID: https://orcid.org/0000-0002-6552-1742)
- Chan‐Hee Lee (ORCID: https://orcid.org/0000-0001-9338-0679)
- H E Kim (ORCID: https://orcid.org/0000-0003-3510-3774)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Daegu Catholic University (KR)
- Daegu Catholic University Medical Center (KR)
- Gangnam Severance Hospital (KR)
- Yeungnam University Medical Center (KR)
Publication Details
- Journal
- EP Europace
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1093/europace/euaf286
- Citations
- 1
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Pfizer
- Yuhan
- Daiichi-Sankyo
- Korea Health Industry Development Institute
- Abbott Korea